Search results for: paradigm biopharmaceuticals limited

Filter by:

Date range:
From
To
Categories:
Tags:
Authors:

Showing 1 - 3 of 3 results

7 September 2016
Dr Lara Herrero

Ross River virus battle breakthrough

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.

Environment + Sustainability Health + Wellbeing Institute for Biomedicine and Glycomics Institute for Glycomics Science and Environment
Read More
19 December 2019
Read More
7 October 2016

Glycomics Week celebrates Institute’s major translational outcomes

The Institute forGlycomics has been delivering major translational outcomes from its research in recent months, which will be celebrated during...

Health + Wellbeing Science + Technology Griffith Sciences Institute for Biomedicine and Glycomics Institute for Glycomics
Read More